Current Review on High-Risk Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 96, doi. 10.1007/s11899-017-0368-z
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2017 AND VI 12 AND IP 2
Results: 8
1
2
An Evidence-Based Approach to Myeloma Bone Disease.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 109, doi. 10.1007/s11899-017-0370-5
- By:
- Publication type:
- Article
3
Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 143, doi. 10.1007/s11899-017-0371-4
- By:
- Publication type:
- Article
4
New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 136, doi. 10.1007/s11899-017-0372-3
- By:
- Publication type:
- Article
5
CARs in the Lead Against Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 119, doi. 10.1007/s11899-017-0373-2
- By:
- Publication type:
- Article
6
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 126, doi. 10.1007/s11899-017-0374-1
- By:
- Publication type:
- Article
7
The Role of Early Molecular Response in the Management of Chronic Phase CML.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 79, doi. 10.1007/s11899-017-0375-0
- By:
- Publication type:
- Article
8
POEMS Syndrome: an Enigma.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 2, p. 85, doi. 10.1007/s11899-017-0367-0
- By:
- Publication type:
- Article